非酒精性脂肪性肝病与2型糖尿病发病关联的种族差异:CARDIA研究结果
基于CARDIA前瞻性队列1995名基线无2型糖尿病的非亚洲成人,基线(2010—2011)行腹部CT、随访(2015—2016)评估血糖。经多变量调整,白人中NAFLD与2型糖尿病风险差为4.1%(95%CI 0.3%,7.9%),黑人中为-1.9%(95%CI -5.7%,2.0%)。作者认为NAFLD与白人2型糖尿病风险升高相关,黑人中未见此关联。
要点
- 白人参与者中,NAFLD与2型糖尿病风险差为4.1%(95%CI 0.3%,7.9%)。
- 黑人参与者中,NAFLD与2型糖尿病风险差为-1.9%(95%CI -5.7%,2.0%)。
- 作者认为肝脏脂肪对糖代谢受损的影响在黑人中可能小于白人。
核心结论
- NAFLD与白人参与者2型糖尿病风险升高相关,与黑人参与者未见此关联。
- 作者认为肝脏脂肪对糖代谢受损的影响在黑人中可能小于白人。
研究设计与样本
- CARDIA研究为基于人群的前瞻性队列研究,基线(2010—2011)行非增强腹部CT,随访(2015—2016)评估血糖。
- 共分析1995名基线无2型糖尿病的非亚洲成人,平均年龄±SD为50.0±3.6岁,59%为女性,55.0%为白人、45.0%为黑人。
- NAFLD定义为排除其他肝脏脂肪原因后CT图像上肝脏衰减≤51 Hounsfield单位,种族为自我报告。
- 采用靶向最大似然估计(TMLE)结合机器学习算法估计NAFLD组与非NAFLD组2型糖尿病风险差。
主要发现
- 基线时白人参与者中21.7%、黑人参与者中16.8%存在NAFLD。
- 随访时白人参与者中3.7%、黑人参与者中8.0%发生2型糖尿病。
- 多变量调整后,NAFLD vs 无NAFLD的2型糖尿病风险差在白人参与者中为4.1%(95%CI 0.3%,7.9%)。
- 多变量调整后,NAFLD vs 无NAFLD的2型糖尿病风险差在黑人参与者中为-1.9%(95%CI -5.7%,2.0%)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) are prevalent diseases of metabolic origin. We examined the association between NAFLD and the development of type 2 diabetes among non-Asian adults, and whether the association differs by race. METHODS: We analysed data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based prospective cohort study. Participants underwent non-contrast abdominal computed tomography (CT) at baseline (2010-2011) and assessment of glucose measures at the follow-up exam (2015-2016). NAFLD was defined as liver attenuation ≤51 Hounsfield units on CT images after exclusion for other liver fat causes. Race was self-reported. We used targeted maximum likelihood estimation (TMLE) with machine-learning algorithms to estimate difference in type 2 diabetes risk between the NAFLD and non-NAFLD groups. RESULTS: Of the 1995 participants without type 2 diabetes at baseline (mean age±SD, 50.0±3.6 years; 59% women; 55.0% White and 45.0% Black), 21.7% of White and 16.8% of Black participants had NAFLD at baseline, and 3.7% of White and 8.0% of Black participants developed type 2 diabetes at follow up. After multivariable adjustment, risk difference for type 2 diabetes associated with NAFLD vs no NAFLD was 4.1% (95% CI 0.3%, 7.9%) among White participants and -1.9% (95% CI -5.7%, 2.0%) in Black participants. CONCLUSIONS/INTERPRETATION: NAFLD was associated with a higher risk of type 2 diabetes among White participants but not among Black participants. This finding suggests that the effect of liver fat on impaired glucose metabolism may be smaller in Black than in White individuals.
引用
- Hatano Y, VanWagner LB, Carnethon MR, et al. Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study. Diabetologia. 2023. PMID: 36941389. doi:10.1007/s00125-023-05903-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。